Clearside Biomedical, Inc. Quarterly Operating Margin in % from Q4 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Clearside Biomedical, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2019 to Q3 2024.
  • Clearside Biomedical, Inc. Operating Margin for the quarter ending September 30, 2024 was -320 %, a 76.4% increase year-over-year.
  • Clearside Biomedical, Inc. annual Operating Margin for 2023 was -302 %, a 86.8% increase from 2022.
  • Clearside Biomedical, Inc. annual Operating Margin for 2022 was -2.28K %, a 107521% decline from 2021.
  • Clearside Biomedical, Inc. annual Operating Margin for 2021 was -2.12 %, a 99.1% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -320 +1.04K +76.4% Jul 1, 2024 Sep 30, 2024
Q2 2024 -342 +1.49K +81.3% Apr 1, 2024 Jun 30, 2024
Q1 2024 -301 +2.77K +90.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 -302 +1.98K +86.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -1.36K -1.34K -10244% Jul 1, 2023 Sep 30, 2023
Q2 2023 -1.83K -1.83K -32380% Apr 1, 2023 Jun 30, 2023
Q1 2023 -3.07K -3.07K -1208506% Jan 1, 2023 Mar 31, 2023
Q4 2022 -2.28K -2.28K -107521% Oct 1, 2022 Dec 31, 2022
Q3 2022 -13.1 +665 +98.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -5.65 +558 +99% Apr 1, 2022 Jun 30, 2022
Q1 2022 0.25 +612 Jan 1, 2022 Mar 31, 2022
Q4 2021 -2.12 +225 +99.1% Oct 1, 2021 Dec 31, 2021
Q3 2021 -678 -537 -382% Jul 1, 2021 Sep 30, 2021
Q2 2021 -563 -291 -107% Apr 1, 2021 Jun 30, 2021
Q1 2021 -612 -326 -114% Jan 1, 2021 Mar 31, 2021
Q4 2020 -227 +1.17K +83.7% Oct 1, 2020 Dec 31, 2020
Q3 2020 -141 Jul 1, 2020 Sep 30, 2020
Q2 2020 -272 Apr 1, 2020 Jun 30, 2020
Q1 2020 -286 Jan 1, 2020 Mar 31, 2020
Q4 2019 -1.39K Oct 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.